Anti-Mesothelin CAR T cell therapy for malignant mesothelioma

Malignant mesothelioma (MM) is a treatment-resistant tumor originating in the mesothelial lining of the pleura or the abdominal cavity with very limited treatment options. More effective therapeutic approaches are urgently needed to improve the poor prognosis of MM patients. Chimeric Antigen Recepto...

Descripción completa

Detalles Bibliográficos
Autores principales: Castelletti, Laura, Yeo, Dannel, van Zandwijk, Nico, Rasko, John E. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885509/
https://www.ncbi.nlm.nih.gov/pubmed/33588928
http://dx.doi.org/10.1186/s40364-021-00264-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885509/
https://www.ncbi.nlm.nih.gov/pubmed/33588928
http://dx.doi.org/10.1186/s40364-021-00264-1

Ejemplares similares